Calorie restriction, physical activity and the drug dapagliflozin caused 44% of participants in a small trial to enter ...

Announcing a new article publication for BIO Integration journal.   Diabetes, a common metabolic condition, poses a substantial health burden worldwide. To revolutionize diabetes management, enhance ...

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...

NDA accepted for review Zynquista (Lexicon Pharmaceuticals) Dual sodium-glucose co-transporter types 1 and 2 inhibitor As an adjunct to insulin therapy for glycemic control in adults with type 1 ...

Metformin use may be linked to a lower risk for dementia in patients with type 2 diabetes, a meta-analysis of over 3.4 ...

The study offers promising news for people with type 2 diabetes. By using SGLT2 inhibitors, they may be able to lower their ...

Farxiga (dapagliflozin) is an orally administered, brand-name medication classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor. SGLT2 inhibitors help lower blood sugar by causing the ...